AB Science S.A. (ABSCF) Financials
ABSCF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2025 | 25.0 million | 57.2 million |
| Dec. 31, 2024 | 24.1 million | 48.9 million |
| June 30, 2024 | 24.7 million | 51.1 million |
| March 31, 2024 | 24.8 million | 51.4 million |
ABSCF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2025 | -5.0 million | 2.4 million |
| Dec. 31, 2024 | -3.0 million | -69769 |
| June 30, 2024 | 3.5 million | ? |
| March 31, 2024 | 1.7 million | ? |
ABSCF Net Income
No data available :(
ABSCF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2025 | 5.9 million | 18.2 million | 1.1 million |
| Dec. 31, 2024 | 8.3 million | 14.6 million | 691446 |
| June 30, 2024 | 9.8 million | 17.4 million | 929653 |
| March 31, 2024 | 9.9 million | - | - |
ABSCF Shares Outstanding
ABSCF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2025 | 163833 | 3.4 million | 1.2 million | 176799 |
| Dec. 31, 2024 | 66645 | 378004 | 2.0 million | 131208 |
| June 30, 2024 | 97688 | 2.8 million | 1.6 million | 203965 |
| March 31, 2024 | 49105 | 1.4 million | 698813 | 102528 |
ABSCF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2025 | 607010 | 429032 |
| Dec. 31, 2024 | 533163 | -280119 |
| June 30, 2024 | 601161 | 99835 |
| March 31, 2024 | 302189 | 50185 |
ABSCF
Price: $1.12
52 week price:
Earnings Per Share: -0.18 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 78.1 million